VANGUARD GROUP INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$7,402,241
+8.1%
600,344
+7.8%
0.00%
Q2 2023$6,848,615
+21.5%
556,798
+21.4%
0.00%
Q1 2023$5,635,223
-16.4%
458,521
-22.0%
0.00%
Q4 2022$6,738,720
+195.6%
588,021
-3.3%
0.00%
Q3 2022$2,280,000
-37.0%
607,804
-0.1%
0.00%
Q2 2022$3,619,000
-5.9%
608,2040.0%0.00%
Q1 2022$3,847,000
+59.6%
608,204
-1.4%
0.00%
Q4 2021$2,411,000
-19.3%
616,848
-0.3%
0.00%
Q3 2021$2,988,000
-24.4%
618,6090.0%0.00%
Q2 2021$3,953,000
+1.8%
618,6090.0%0.00%
Q1 2021$3,885,000
-4.5%
618,609
+4.7%
0.00%
Q4 2020$4,070,000
+102.3%
590,622
+17.4%
0.00%
Q3 2020$2,012,000
+20.1%
503,0270.0%0.00%
Q2 2020$1,675,000
+54.8%
503,0270.0%0.00%
Q1 2020$1,082,000
-31.7%
503,0270.0%0.00%
Q4 2019$1,584,000
-28.7%
503,027
+1.6%
0.00%
Q3 2019$2,222,000
-2.6%
495,027
+31.3%
0.00%
Q2 2019$2,281,000
+45.9%
377,010
+67.6%
0.00%
Q1 2019$1,563,000
+85.2%
224,930
+2.8%
0.00%
Q4 2018$844,000
-71.0%
218,757
-60.0%
0.00%
Q3 2018$2,913,000
+7.3%
546,632
-1.1%
0.00%
Q2 2018$2,714,000
-43.7%
552,852
-7.6%
0.00%
Q1 2018$4,817,000
-28.1%
598,410
-8.5%
0.00%
Q4 2017$6,703,000
-24.6%
653,931
+7.0%
0.00%
Q3 2017$8,885,000610,9970.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders